Additionally, all of the hypermutated samples contained other exonic POLE variants of both benign and uncertain impact, occurring both within and outside functional domains of the POLE gene, whereas the non-cancer control and the non-hypermutated endometrial cancer samples each had only a single benign mutation. The gene discussed is POLE; the disease is cancer.